Correspondence
Letter to the Editor about “Prevalence of neutralizing antibodies against SARS-CoV-2 using a rapid serological test in health workers before the booster dose of the vaccine”
Carta replica a “Prevalencia de anticuerpos neutralizantes frente al SARS-CoV-2 inducidos tras 2 dosis de vacuna BNT162b2 (Pfizer–BioNTech) en trabajadores sanitarios”
Read
352
Timeswas read the article
2
Total PDF
350
Total HTML
Share statistics
array:24 [ "pii" => "S2254887424000900" "issn" => "22548874" "doi" => "10.1016/j.rceng.2024.06.011" "estado" => "S300" "fechaPublicacion" => "2024-08-01" "aid" => "2214" "copyright" => "Elsevier España, S.L.U. and Sociedad Española de Medicina Interna (SEMI)" "copyrightAnyo" => "2024" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Rev Clin Esp. 2024;224:481" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "Traduccion" => array:1 [ "es" => array:19 [ "pii" => "S0014256524001115" "issn" => "00142565" "doi" => "10.1016/j.rce.2024.05.006" "estado" => "S300" "fechaPublicacion" => "2024-08-01" "aid" => "2214" "copyright" => "Elsevier España, S.L.U. and Sociedad Española de Medicina Interna (SEMI)" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Rev Clin Esp. 2024;224:481" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "es" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Correspondencia</span>" "titulo" => "Carta réplica a «Prevalencia de anticuerpos neutralizantes frente al SARS-CoV-2 inducidos tras 2 dosis de vacuna BNT162b2 (Pfizer–BioNTech) en trabajadores sanitarios»" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:1 [ "paginaInicial" => "481" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Letter to the Editor about “Prevalence of neutralizing antibodies against SARS-CoV-2 using a rapid serological test in health workers before the booster dose of the vaccine”" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "H. Daungsupawong, V. Wiwanitkit" "autores" => array:2 [ 0 => array:2 [ "nombre" => "H." "apellidos" => "Daungsupawong" ] 1 => array:2 [ "nombre" => "V." "apellidos" => "Wiwanitkit" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S2254887424000900" "doi" => "10.1016/j.rceng.2024.06.011" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2254887424000900?idApp=WRCEE" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0014256524001115?idApp=WRCEE" "url" => "/00142565/0000022400000007/v1_202408020450/S0014256524001115/v1_202408020450/es/main.assets" ] ] "itemSiguiente" => array:19 [ "pii" => "S2254887424000857" "issn" => "22548874" "doi" => "10.1016/j.rceng.2024.06.006" "estado" => "S300" "fechaPublicacion" => "2024-08-01" "aid" => "2216" "copyright" => "Elsevier España, S.L.U. and Sociedad Española de Medicina Interna (SEMI)" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Rev Clin Esp. 2024;224:482-3" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "en" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Correspondence</span>" "titulo" => "Counter reply in reference to “Prevalence of neutralizing antibodies against SARS-CoV-2 using a rapid serological test in health workers of a Spanish Department of Health in Alicante (Spain) before the booster dose of the vaccine”" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "482" "paginaFinal" => "483" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Respuesta a la carta al Director sobre «Prevalencia de anticuerpos neutralizantes frente al SARS-CoV-2 inducidos tras 2 dosis de vacuna BNT162b2 (Pfizer–BioNTech) en trabajadores sanitarios»" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "A.C. Montagud, J. Llenas-García, R. Moragues, A. Pérez-Bernabeu, M.J. Alcocer Pertegal, F.J. García Gómez, A.M. Gamayo Serna, H. García Morante, P. Caballero, J. Tuells" "autores" => array:10 [ 0 => array:2 [ "nombre" => "A.C." "apellidos" => "Montagud" ] 1 => array:2 [ "nombre" => "J." "apellidos" => "Llenas-García" ] 2 => array:2 [ "nombre" => "R." "apellidos" => "Moragues" ] 3 => array:2 [ "nombre" => "A." "apellidos" => "Pérez-Bernabeu" ] 4 => array:2 [ "nombre" => "M.J." "apellidos" => "Alcocer Pertegal" ] 5 => array:2 [ "nombre" => "F.J." "apellidos" => "García Gómez" ] 6 => array:2 [ "nombre" => "A.M." "apellidos" => "Gamayo Serna" ] 7 => array:2 [ "nombre" => "H." "apellidos" => "García Morante" ] 8 => array:2 [ "nombre" => "P." "apellidos" => "Caballero" ] 9 => array:2 [ "nombre" => "J." "apellidos" => "Tuells" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0014256524001139" "doi" => "10.1016/j.rce.2024.06.001" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0014256524001139?idApp=WRCEE" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2254887424000857?idApp=WRCEE" "url" => "/22548874/0000022400000007/v1_202408020531/S2254887424000857/v1_202408020531/en/main.assets" ] "itemAnterior" => array:18 [ "pii" => "S2254887424000833" "issn" => "22548874" "doi" => "10.1016/j.rceng.2024.06.004" "estado" => "S300" "fechaPublicacion" => "2024-08-01" "aid" => "2208" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "edi" "cita" => "Rev Clin Esp. 2024;224:479-80" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "en" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Editorial</span>" "titulo" => "The young internist at the leading edge of clinical research" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "479" "paginaFinal" => "480" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "El internista joven a la vanguardia de la investigación clínica" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "F. Pérez-Jiménez, P. Pérez-Martínez" "autores" => array:2 [ 0 => array:2 [ "nombre" => "F." "apellidos" => "Pérez-Jiménez" ] 1 => array:2 [ "nombre" => "P." "apellidos" => "Pérez-Martínez" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S001425652400105X" "doi" => "10.1016/j.rce.2024.05.002" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S001425652400105X?idApp=WRCEE" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2254887424000833?idApp=WRCEE" "url" => "/22548874/0000022400000007/v1_202408020531/S2254887424000833/v1_202408020531/en/main.assets" ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Correspondence</span>" "titulo" => "Letter to the Editor about “Prevalence of neutralizing antibodies against SARS-CoV-2 using a rapid serological test in health workers before the booster dose of the vaccine”" "tieneTextoCompleto" => true "saludo" => "Dear Editor," "paginas" => array:1 [ 0 => array:1 [ "paginaInicial" => "481" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "H. Daungsupawong, V. Wiwanitkit" "autores" => array:2 [ 0 => array:4 [ "nombre" => "H." "apellidos" => "Daungsupawong" "email" => array:1 [ 0 => "hinpetchdaung@gmail.com" ] "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor0005" ] ] ] 1 => array:4 [ "nombre" => "V." "apellidos" => "Wiwanitkit" "email" => array:1 [ 0 => "wviroj@yahoo.com" ] "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] ] ] ] "afiliaciones" => array:2 [ 0 => array:3 [ "entidad" => "Private Academic Consultant, Phonhong, Lao People's Democratic Republic" "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:3 [ "entidad" => "Department of Research Analytics, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences Saveetha University, Chennai, India" "etiqueta" => "b" "identificador" => "aff0010" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Carta replica a “Prevalencia de anticuerpos neutralizantes frente al SARS-CoV-2 inducidos tras 2 dosis de vacuna BNT162b2 (Pfizer–BioNTech) en trabajadores sanitarios”" ] ] "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">We would like to share our opinion on the publication “Prevalencia de anticuerpos neutralizantes frente al SARS-CoV-2 inducidos tras 2 dosis de vacuna BNT162b2 (Pfizer–BioNTech) en trabajadores sanitarios.”<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a> A study that included 1,500 workers was conducted in the Health Department of Orihuela, Alicante (Spain) to measure the presence of neutralizing antibodies prior to the administration of a third vaccine dose. Demographic variables were collected and an immunochromatography test was performed using the OJABIO® SARS-CoV-2 neutralizing antibody detection kit. The results showed that 38.5% of the participants had neutralizing antibodies, with important predictive factors being time since the last vaccine dose and previous SARS-CoV-2 infection.</p><p id="par0010" class="elsevierStylePara elsevierViewall">Only 64% of workers had complete information, which may have introduced selection bias and affect the ability to extrapolate the results. The study did not provide information on the specific characteristics of participants who tested positive for neutralizing antibodies, which limits the understanding of factors that influence the presence of antibodies. The study did not investigate other potential factors that may have an influence on the presence of neutralizing antibodies, such as the vaccine type or underlying health conditions.</p><p id="par0015" class="elsevierStylePara elsevierViewall">For future guidance, the participation rate should be increased to ensure a more representative sample of the workforce. Furthermore, detailed information on the characteristics of participants with neutralizing antibodies should be included in order to identify potential trends or risk factors. In addition, it should be considered whether to explore additional factors that may influence the presence of antibodies, such as the type of vaccine, comorbidities, or variations in the immune response.</p><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0005">Conflict of interest</span><p id="par0020" class="elsevierStylePara elsevierViewall">The authors declare that they have no conflict of interest.</p></span></span>" "textoCompletoSecciones" => array:1 [ "secciones" => array:2 [ 0 => array:2 [ "identificador" => "sec0005" "titulo" => "Conflict of interest" ] 1 => array:1 [ "titulo" => "Reference" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "bibliografia" => array:2 [ "titulo" => "Reference" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:1 [ 0 => array:3 [ "identificador" => "bib0005" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Prevalencia de anticuerpos neutralizantes frente al SARS-CoV-2 inducidos tras 2 dosis de vacuna BNT162b2 (Pfizer–BioNTech) en trabajadores sanitarios" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "A.C. Montagud" 1 => "J. Llenas-García" 2 => "R. Moragues" 3 => "A. Pérez-Bernabeu" 4 => "M.J.A. Pertegal" 5 => "F.J.G. Gómez" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.rce.2024.01.009" "Revista" => array:6 [ "tituloSerie" => "Rev Clin Esp." "fecha" => "2024" "volumen" => "224" "paginaInicial" => "197" "paginaFinal" => "203" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/38423384" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/22548874/0000022400000007/v1_202408020531/S2254887424000900/v1_202408020531/en/main.assets" "Apartado" => array:4 [ "identificador" => "71813" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Correspondence" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/22548874/0000022400000007/v1_202408020531/S2254887424000900/v1_202408020531/en/main.pdf?idApp=WRCEE&text.app=https://revclinesp.es/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2254887424000900?idApp=WRCEE" ]
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 October | 42 | 0 | 42 |
| 2024 September | 35 | 0 | 35 |
| 2024 August | 51 | 0 | 51 |
| 2024 July | 222 | 2 | 224 |
